home / stock / rgrx / rgrx quote
Last: | $0.0014 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0014 |
High: | $0 |
Low: | $0 |
Volume: | 5 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0014 | $0 | $0.0014 | $0 | $0 | 5 | 07-29-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 20 | 07-26-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 2,498 | 07-25-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 20 | 07-23-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 4 | 07-22-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 27 | 07-10-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 34 | 07-05-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 110 | 07-04-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 110 | 07-03-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 20 | 07-01-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 117 | 06-21-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 474 | 06-13-2024 |
$0.0522 | $0 | $0.0522 | $0 | $0 | 2 | 06-12-2024 |
$0.0522 | $0 | $0.0522 | $0 | $0 | 1 | 06-11-2024 |
$0.0522 | $0.0522 | $0.0522 | $0.0522 | $0.0522 | 420 | 06-06-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 400 | 05-29-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 104 | 05-21-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 3 | 05-13-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 30 | 05-10-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 3 | 05-09-2024 |
News, Short Squeeze, Breakout and More Instantly...
Regenerx Biopharms Inc Company Name:
RGRX Stock Symbol:
OTCMKTS Market:
RegeneRx Effects Reverse Stock Split and Terminates SEC Reporting Obligations PR Newswire ROCKVILLE, Md. , Aug. 15, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("RegeneRx" or the "Company") , a clinical-stage drug development compa...
RegeneRx Receives Stockholder Approval for Reverse Stock Split PR Newswire ROCKVILLE, Md. , Aug. 7, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("RegeneRx" or the "Company") , a clinical-stage drug development company focused o...
RegeneRx To Extend Consent Solicitation Vote PR Newswire ROCKVILLE, Md. , Aug. 1, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("RegeneRx" or "Company"), a clinical-stage drug development company focused on tissue protection, repair, and...